XML 59 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value, Option, Quantitative Disclosures [Line Items]  
Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on Recurring Basis

The following table presents information about the Company’s financial assets, financial liabilities, and investments measured at fair value on a recurring basis and indicates the level of the fair value hierarchy utilized to determine such fair values:

 

 

As of December 31, 2024:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (money market)

 

$

17,636

 

 

$

-

 

 

$

-

 

 

$

17,636

 

U.S. Treasury securities

 

 

-

 

 

 

86,504

 

 

 

-

 

 

 

86,504

 

Investments:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

-

 

 

 

7,012

 

 

 

-

 

 

 

7,012

 

 

$

17,636

 

 

$

93,516

 

 

$

-

 

 

$

111,152

 

 

 

 

As of December 31, 2023:

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents (money market)

 

$

102,484

 

 

$

-

 

 

$

-

 

 

$

102,484

 

U.S. Treasury securities

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Investments:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

$

102,484

 

 

$

-

 

 

$

-

 

 

$

102,484

 

Schedule of Investments Classified as Available-for-Sale Securities

Investments, which are classified as available-for-sale securities, consisted of the following as of December 31, 2024 and December 31, 2023:

 

 

As of December 31, 2024:

 

 

 

Amortized Cost Basis

 

 

Gross Unrealized Gains

 

 

Gross Unrealized Losses

 

 

Fair Value

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

$

93,619

 

 

$

-

 

 

$

(103

)

 

$

93,516

 

 

$

93,619

 

 

$

-

 

 

$

(103

)

 

$

93,516

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2023:

 

 

 

Amortized Cost Basis

 

 

Gross Unrealized Gains

 

 

Gross Unrealized Losses

 

 

Fair Value

 

Available-for-sale securities:

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury securities

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Schedule of Aggregate Fair Values of Investments Classified as Available-for-Sale Securities With Unrealized Losses and Gains

Aggregate fair values of investments classified as available-for-sale securities with unrealized losses and gains were as follows as of December 31, 2024 and December 31, 2023:

 

 

December 31, 2024

 

 

December 31, 2023

 

Available-for-sale securities:

 

 

 

 

 

 

Due within one year

 

$

86,504

 

 

$

-

 

Due after one year through five years

 

$

7,012

 

 

 

-

 

 

 

$

93,516

 

 

$

-

 

Schedule of Rollforward of Changes in Fair Value of Financial Liabilities

The following table sets forth a roll forward of changes in the fair value of financial liabilities, gross of unamortized discount, classified as Level 3 in the fair value hierarchy:

 

 

Convertible
SAFE Note,
gross

 

Beginning balance at December 31, 2022

 

$

 

Convertible SAFE Note issuance at August 24, 2023

 

 

4,000

 

Change in estimated fair value since issuance

 

 

530

 

Conversion of SAFE Note into common stock in connection with initial public offering

 

 

(4,530

)

Ending balance at December 31, 2023

 

$

 

 

Schedule of Significant Unobservable Inputs Used in Valuation Model to Estimate Fair Value The ranges of the significant unobservable inputs used in the valuation model to estimate the fair value of the Company’s convertible SAFE Note that was categorized within Level 3 of the fair value hierarchy as of August 24, 2023 (issuance) until November 2, 2023 (settlement) were as follows (not stated in thousands):

Probability of meeting qualified equity financing event

 

10.0% - 20.0%

Probability of meeting public offering event

 

75.0% - 85.0%

Probability of meeting change in control event

 

5%

Time until qualified equity financing event (in years)

 

0.17 - 0.27

Time until public offering event (in years)

 

0.08 - 0.19

Time until change in control event (in years)

 

0.50 - 0.60

IPO  
Fair Value, Option, Quantitative Disclosures [Line Items]  
Summary of Estimated Fair Value Assumptions The total grant date fair value of this option of approximately $1.2 million, or $0.85 per share, was recorded as an offset to additional paid-in capital and was estimated using a Black-Scholes model incorporating the following assumptions (not stated in thousands):

Stock price

 

$

11.00

 

Exercise price

 

$

11.00

 

Weighted average risk-free interest rate

 

5.53%

 

Expected term (in years)

 

0.08

 

Expected volatility

 

65.88%

 

Expected dividend yield

 

0.00%